Cargando…
Liver transplantation in elderly patients: what do we know at the beginning of 2020?
An aging population has prompted us to evaluate the indications of liver transplantation (LT) in elderly patients more frequently. In this review, we summarize the short- and long-term results after LT in elderly patients and also discuss the criteria used to select patients and how recipient age ca...
Autores principales: | Dolnikov, Shimon, Adam, René, Cherqui, Daniel, Allard, Marc Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239827/ https://www.ncbi.nlm.nih.gov/pubmed/32279191 http://dx.doi.org/10.1007/s00595-020-01996-7 |
Ejemplares similares
-
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
por: Yoo, Jin-Hong
Publicado: (2021) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
The Role of Testosterone in the Elderly: What Do We Know?
por: Barone, Biagio, et al.
Publicado: (2022) -
Trastuzumab-related cardiotoxicity: what do we know in 2020?
por: Liu, Jia, et al.
Publicado: (2020) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)